You are subscribed to the Formulary News Capsule.

Formulary

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

September 20, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

Today's Headlines

First generic Xeloda

FDA has approved the oral chemotherapy tablet capecitabine, the first generic version of Teva's Xeloda, to treat cancer of the colon or rectum that has spread to other parts of the body. It also approved generic capecitabine for treatment of metastatic breast cancer. » Full article

Effects of varenicline in smokers with depression

About half of smokers seeking treatment for smoking cessation have a history of depression. Compared with smokers who are not depressed, those who suffer from a major depressive disorder have greater difficulty quitting, according to a study published September 17 in the Annals of Internal Medicine. » Full article

ADVERTISEMENT

Can Some TG-Lowering Therapies Impact LDL-C?

Prescriptions 300% higher in some docs' offices

Filling a prescription at a doctor's office may be convenient, but it's certainly no bargain for patients or taxpayers, according to an analysis of workers' compensation payouts in Maryland and Pennsylvania. » Full article

Rx drug abuse

In order to help combat the national prescription drug abuse epidemic, CVS Caremark is tapping its extensive database to identify and halt inappropriate prescribing of high-risk drugs such as opioid painkillers. » Full article

Continuing Education

New Mini-Series: Osteoporosis Care

This month, Drug Topics offers the first part of a two-part CPE series, "MTM considerations in osteoporosis care." Earn up to 2 credits by completing this application-based activity.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

 

Related Articles

FDA approves late-stage pancreatic cancer injectable

Naltrexone plus prolonged exposure therapy helps alcohol-dependent PTSD patients

Unauthorized prescribers bill Part D $5 million

Study finds Rx abuse among teens is a big problem

RESOURCES

Drug Watch

Latest Clinical News

EDITOR'S PICK

VIDEO: Recognizing pharmacists as healthcare providers—a solution for the Patient Protection and Affordable Care Act roll-out

Video

As described in the Patient Protection and Affordable Care Act, one of its key benefits is the increased availability of preventive care services. These services range from immunizations to wellness visits for Medicaid and Medicare patients. Expansion of these services will put an increased workload on already time-strapped healthcare providers. In addition, patients in rural or medically underserved areas may not receive access to these benefits because of severely limited access to providers. The average American lives within 5 miles or less of the nearest community pharmacy. And that puts community pharmacy in a unique position to help America close the gap on patient access, and bring greater affordability to healthcare costs. » Full article

 
Powered by Modern Medicine Advanstar Medical Communications Group